|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease显示文摘 | Sabatine MS Morrow DA Jablonski KA | 2007 | Circulation2007，115，12： | 1 |
| 2 | Repeated swim-stress reduces GABAA receptor alpha subunit mRNAs in the mouse hippocampus 显示文摘 | Montpied P Weizman A Weizman R Kook KA Morrow AL Paul SM | 1993 | Brain Res Mol Brain Res1993，18，3： | 1 |
| 3 | Evaluation of a novel antiplatetet a- gent for secondary- prevention in patients with a history of atherosclerotic dis- ease: design and rationale for the Thrombin-Reeeptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events ( TRA 2 degrees P) -TIMI 50 trial显示文摘 | Morrow DA Scirica BM Fox KA | 2009 | Am Heart J2009，158，： | 1 |
| 4 | Prognostic signifi- cance of the Centers for Disease Control/American Heart Associa- tion high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease 显示文摘 | Sabatine MS Morrow DA Jablonski KA | 2007 | Circulation2007，115，12： | 1 |
| 5 | Prognostic signifi-cance of lhe centers for disease controVAmefican heart association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery, disease显示文摘 | Sabatine MS Morrow DA Jablonski KA | 2007 | Circulation2007，115，12： | 1 |
| 6 | Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease显示文摘 | Sabatine MS Morrow DA Jablonski KA | 2007 | Circulation2007，115，12： | 1 |
| 7 | Safety,efficacy,and immu- nogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intrae- pithelial neoplasia 2/3:a randomised,double-blind,placebo-controlled phase 2b trial显示文摘 | Tfimble CL Morrow MP Kraynyak KA | 2015 | Lancet2015，386，10008： | 1 |
| 8 | Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease显示文摘 | Sabatine MS Morrow DA Jablonski KA | 2007 | Circulation2007，115，12： | 1 |
| 9 | Loss of tumor suppressor Merlin in advanced breast cancer is due to post-translational regulation显示文摘 | Morrow KA Das S Metge BJ | | 0，，46： | 1 |
| 10 | Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease显示文摘 | Sabatine MS Morrow DA Jabloski KA | | 0，，： | 1 |
| 11 | Loss of tumor suppressor Merlin in advanced breast cancer is due to post-translational regulation显示文摘 | Morrow KA Das S Metge BJ | 2011 | J Biol Chem2011，286，40： | 1 |
| 12 | Prognostic signifi-cance of the Centers for Disease Control/ American Heart Associa-tion high-sensitivity C-reactive protein cut points for cardiovascularand other outcomes in patients with stable coronary artery disease显示文摘 | Sabatine MS Morrow DA Jablonski KA | 2007 | Circulation2007，115，12： | 1 |
| 13 | Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease显示文摘 | Sabatine MS Morrow DA Jablonski KA | 2007 | Circulation2007，115，12： | 1 |
| 14 | Asynthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates显示文摘 | Muthumani K Falzarano D Reuschel E L Tingey C Flingai S Villarreal DO Wise M Patel A Izmirly A Aljuaid A Seliga AM Soule G Morrow M Kraynyak KA Khan AS Scott DP Feldmann F LaCasse R White KM Okumura A Ugen KE Sardesai NY Kim JJ Kobinger G Feldmann H Weiner DB | 2015 | Sci Transl Med2015，7，301： | 1 |
| 15 | Prognostic aignificanca of the Centers for Disease Control/American Heart Association high- sensitivity C- reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease 显示文摘 | Sabatine MS Morrow DA Jablonski KA | 2007 | Circulation2007，115，12： | 1 |
| 16 | Safety,efficacy,and immunogenicity of VGX-3100,a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18E6 and E7 proteins for cervical intraepithelial neoplasia 2/3:a randomised,double-blind,placebo-controlled phase 2b trial显示文摘 | Trimble CL Morrow MP Kraynyak KA | 2015 | Lancet2015，386，： | 1 |
| 17 | Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease显示文摘 | Sabatine MS Morrow DA Jablonski KA | | 0，，12： | 1 |
| 18 | Prognos- tic significance of the Centers for Disease Control/Ameri-can Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in pa- tients with stable coronary artery disease显示文摘 | Sabatine MS Morrow DA Jablonski KA | 2007 | Circulation2007，115，12： | 1 |
| 19 | Pronostie significane of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable cornary artery disease显示文摘 | Sabatine MS Morrow DA JablomskiI KA | 2007 | Circulation2007，115，12： | 1 |
| 20 | Merlin: the wizard requires protein stability to function as a tumor suppressor显示文摘 | Morrow KA Shevde LA | 2012 | Biochim Biophys Aeta2012，1826，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员